Annual report [Section 13 and 15(d), not S-K Item 405]

Organization (Details Narrative)

v3.25.1
Organization (Details Narrative) - USD ($)
12 Months Ended
Jan. 27, 2025
Jan. 22, 2024
Dec. 31, 2024
Dec. 31, 2023
Mar. 12, 2025
Jan. 30, 2025
Jan. 21, 2024
OrganizationLineItems [Line Items]              
Reverse stock split   1-for-20 reverse stock split          
Common stock, par value   $ 0.0001 $ 0.0001 $ 0.0001      
Common stock, shares issued   1,291,000 3,707,628 1,291,000     24,706,474
Common stock, shares outstanding   1,286,000 3,702,628 1,286,000     24,606,474
Common stock, shares authorized   100,000,000 100,000,000 100,000,000      
Accumulated deficit     $ 87,219,199 $ 75,369,081      
Net loss     11,850,118 11,121,520      
Net cash used in operating activities     11,245,042 8,063,346      
Cash and cash equivalents     $ 1,191,325 $ 4,706,197      
Subsequent Event [Member]              
OrganizationLineItems [Line Items]              
Net proceeds $ 4,500,000            
Purchase Agreement [Member] | Subsequent Event [Member]              
OrganizationLineItems [Line Items]              
Number of shares sold 1,030,972            
Net proceeds $ 4,500,000            
Purchase Agreement [Member] | Subsequent Event [Member] | Series A Warrants [Member]              
OrganizationLineItems [Line Items]              
Warrants to purchase common stock 8,050,672            
Purchase Agreement [Member] | Subsequent Event [Member] | Series B Warrants [Member]              
OrganizationLineItems [Line Items]              
Warrants to purchase common stock 4,025,336            
Purchase Agreement [Member] | Subsequent Event [Member] | Pre-Funded Warrants [Member]              
OrganizationLineItems [Line Items]              
Warrants to purchase common stock 7,019,700            
Warrants exercised           525,700  
Warrants outstanding         6,494,000